These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 20045696

  • 1. Toxoplasma gondii: fluconazole and itraconazole activity against toxoplasmosis in a murine model.
    Martins-Duarte ES, Lemgruber L, de Souza W, Vommaro RC.
    Exp Parasitol; 2010 Apr; 124(4):466-9. PubMed ID: 20045696
    [Abstract] [Full Text] [Related]

  • 2. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
    Martins-Duarte ÉS, de Souza W, Vommaro RC.
    Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
    [Abstract] [Full Text] [Related]

  • 3. Nifurtimox plus pyrimethamine for treatment of murine toxoplasmosis.
    Aguirre-Cruz L, Velasco O, Sotelo J.
    J Parasitol; 1998 Oct; 84(5):1032-3. PubMed ID: 9794648
    [Abstract] [Full Text] [Related]

  • 4. Depletion of CD4+ T cells but not inhibition of the protective activity of IFN-gamma prevents cure of toxoplasmosis mediated by drug therapy in mice.
    Araujo FG.
    J Immunol; 1992 Nov 01; 149(9):3003-7. PubMed ID: 1357033
    [Abstract] [Full Text] [Related]

  • 5. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.
    Ferreira RA, Oliveira AB, Ribeiro MF, Tafuri WL, Vitor RW.
    Exp Parasitol; 2006 Jun 01; 113(2):125-9. PubMed ID: 16458300
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of spiramycin in murine models of acute and chronic toxoplasmosis.
    Grujić J, Djurković-Djaković O, Nikolić A, Klun I, Bobić B.
    Int J Antimicrob Agents; 2005 Mar 01; 25(3):226-30. PubMed ID: 15737517
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A new combined flow-cytometry-based assay reveals excellent activity against Toxoplasma gondii and low toxicity of new bisphosphonates in vitro and in vivo.
    Shubar HM, Mayer JP, Hopfenmüller W, Liesenfeld O.
    J Antimicrob Chemother; 2008 May 01; 61(5):1110-9. PubMed ID: 18285314
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
    Rodríguez-Díaz JC, Martínez-Grueiro MM, Martínez-Fernández AR.
    Enferm Infecc Microbiol Clin; 1993 Dec 01; 11(10):543-6. PubMed ID: 8142504
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Preliminary application of PCR to curative effect assessment of chemotherapy against experimental acute infection of Toxoplasma gondii in mice].
    Xiang X, Ke OY, Zhang Z.
    Hunan Yi Ke Da Xue Xue Bao; 1997 Dec 01; 22(1):5-7. PubMed ID: 9868016
    [Abstract] [Full Text] [Related]

  • 17. Effect of deferoxamine alone and combined with pyrimethamine on acute toxoplasmosis in mice.
    Mahmoud MS.
    J Egypt Soc Parasitol; 1999 Dec 01; 29(3):791-803. PubMed ID: 12561919
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.